LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab Ozogamicin in AML. Mediterr J Hematol Infect Dis 2020, 12 (1), e2020020. https://doi.org/10.4084/mjhid.2020.020.